Kai Shen, Tong Liu Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Tong LiuDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaEmail tongliu2021@126.comBackground: Stomach adenocarcinoma (STAD) is one of the most prevalent malignances and ranks fifth in incidence and third in the cancer-related deaths among all malignances. The prognosis of STAD is poor. Immunotherapy based on immune checkpoint blockade is ever-increasingly suggested as the most promising therapy strategy for STAD. However, the prognosis and therapy value of immune checkpoints in STAD is far from clarified.Methods: In ou...
Jing-Jing Zhao,1,2,* Zi-Qi Zhou,1,2,* Peng Wang,3,4,* Chang-Long Chen,1,2 Yuan Liu,1,2 Qiu-Zhong Pan...
Gastric cancer is a heterogeneous group of diseases with only a fraction of patients responding to i...
Stomach adenocarcinoma (STAD) is one of the most common malignant tumors of the digestive tract, and...
BackgroundGlobally, stomach adenocarcinoma (STAD)’s high morbidity and mortality should arouse our u...
Stomach adenocarcinoma (STAD) is one of the most common malignancies. But the molecular mechanism is...
Objective: to study the state of cellular immunity in patients with gastric adenocarcinoma.Materials...
Different subtypes of gastric cancer differentially respond to immune checkpoint inhibitors (ICI). T...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Background Gastro-oesophageal adenocarcinomas (GOAs) frequently recur after resection; prognostic a...
Immune checkpoint blockade has attracted a lot of attention in the treatment of human malignant tumo...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Background. There are a few indications known in the world to administer immunotherapy (IT) via immu...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Jing-Jing Zhao,1,2,* Zi-Qi Zhou,1,2,* Peng Wang,3,4,* Chang-Long Chen,1,2 Yuan Liu,1,2 Qiu-Zhong Pan...
Gastric cancer is a heterogeneous group of diseases with only a fraction of patients responding to i...
Stomach adenocarcinoma (STAD) is one of the most common malignant tumors of the digestive tract, and...
BackgroundGlobally, stomach adenocarcinoma (STAD)’s high morbidity and mortality should arouse our u...
Stomach adenocarcinoma (STAD) is one of the most common malignancies. But the molecular mechanism is...
Objective: to study the state of cellular immunity in patients with gastric adenocarcinoma.Materials...
Different subtypes of gastric cancer differentially respond to immune checkpoint inhibitors (ICI). T...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Background Gastro-oesophageal adenocarcinomas (GOAs) frequently recur after resection; prognostic a...
Immune checkpoint blockade has attracted a lot of attention in the treatment of human malignant tumo...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Background. There are a few indications known in the world to administer immunotherapy (IT) via immu...
The pathogenesis and vital factors of early and progressive stages of stomach adenocarcinoma (STAD) ...
Jing-Jing Zhao,1,2,* Zi-Qi Zhou,1,2,* Peng Wang,3,4,* Chang-Long Chen,1,2 Yuan Liu,1,2 Qiu-Zhong Pan...
Gastric cancer is a heterogeneous group of diseases with only a fraction of patients responding to i...
Stomach adenocarcinoma (STAD) is one of the most common malignant tumors of the digestive tract, and...